View in EDS

C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia.

Saved in:
Bibliographic Details
Title: C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia.
Authors: de Boer ECW; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands.; Department of Pediatric Immunology, Rheumatology, and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam, The Netherlands., Jalink M; Department of Clinical Transfusion Research, Sanquin Research, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Department of Transfusion Medicine, Sanquin Blood Supply, Amsterdam, The Netherlands., Delvasto-Nuñez L; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands., Meulenbroek EM; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands., Baas I; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands., Janssen SR; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Folman CC; Department of Immunohematology Diagnostics, Sanquin, Amsterdam, The Netherlands., Gelderman KA; Sanquin Diagnostic Services, Amsterdam, The Netherlands., Wouters D; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Engel MD; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands., de Haas M; Department of Clinical Transfusion Research, Sanquin Research, Amsterdam, The Netherlands.; Department of Immunohematology Diagnostics, Sanquin, Amsterdam, The Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, Location University of Amsterdam, Cancer Center Amsterdam and Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands., Jongerius I; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands.; Department of Pediatric Immunology, Rheumatology, and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam, The Netherlands., Zeerleder S; Department of Hematology, Luzerner Kantonsspital, Luzern, Switzerland.; Department for BioMedical Research, University of Bern, Bern, Switzerland., Vos JMI; Department of Immunohematology Diagnostics, Sanquin, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam University Medical Centers, Location University of Amsterdam, Cancer Center Amsterdam and Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.
Source: Blood advances [Blood Adv] 2023 Jul 11; Vol. 7 (13), pp. 3128-3139.
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36920779
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22de+Boer+ECW%22">de Boer ECW</searchLink>; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands.; Department of Pediatric Immunology, Rheumatology, and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Jalink+M%22">Jalink M</searchLink>; Department of Clinical Transfusion Research, Sanquin Research, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Department of Transfusion Medicine, Sanquin Blood Supply, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Delvasto-Nuñez+L%22">Delvasto-Nuñez L</searchLink>; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Meulenbroek+EM%22">Meulenbroek EM</searchLink>; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Baas+I%22">Baas I</searchLink>; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Janssen+SR%22">Janssen SR</searchLink>; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Folman+CC%22">Folman CC</searchLink>; Department of Immunohematology Diagnostics, Sanquin, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Gelderman+KA%22">Gelderman KA</searchLink>; Sanquin Diagnostic Services, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Wouters+D%22">Wouters D</searchLink>; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Engel+MD%22">Engel MD</searchLink>; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Haas+M%22">de Haas M</searchLink>; Department of Clinical Transfusion Research, Sanquin Research, Amsterdam, The Netherlands.; Department of Immunohematology Diagnostics, Sanquin, Amsterdam, The Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kersten+MJ%22">Kersten MJ</searchLink>; Department of Hematology, Amsterdam University Medical Centers, Location University of Amsterdam, Cancer Center Amsterdam and Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Jongerius+I%22">Jongerius I</searchLink>; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands.; Department of Pediatric Immunology, Rheumatology, and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Zeerleder+S%22">Zeerleder S</searchLink>; Department of Hematology, Luzerner Kantonsspital, Luzern, Switzerland.; Department for BioMedical Research, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Vos+JMI%22">Vos JMI</searchLink>; Department of Immunohematology Diagnostics, Sanquin, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam University Medical Centers, Location University of Amsterdam, Cancer Center Amsterdam and Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2023 Jul 11; Vol. 7 (13), pp. 3128-3139.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36920779
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2022009402
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3128
    Titles:
      – TitleFull: C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: de Boer ECW
      – PersonEntity:
          Name:
            NameFull: Jalink M
      – PersonEntity:
          Name:
            NameFull: Delvasto-Nuñez L
      – PersonEntity:
          Name:
            NameFull: Meulenbroek EM
      – PersonEntity:
          Name:
            NameFull: Baas I
      – PersonEntity:
          Name:
            NameFull: Janssen SR
      – PersonEntity:
          Name:
            NameFull: Folman CC
      – PersonEntity:
          Name:
            NameFull: Gelderman KA
      – PersonEntity:
          Name:
            NameFull: Wouters D
      – PersonEntity:
          Name:
            NameFull: Engel MD
      – PersonEntity:
          Name:
            NameFull: de Haas M
      – PersonEntity:
          Name:
            NameFull: Kersten MJ
      – PersonEntity:
          Name:
            NameFull: Jongerius I
      – PersonEntity:
          Name:
            NameFull: Zeerleder S
      – PersonEntity:
          Name:
            NameFull: Vos JMI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 07
              Text: 2023 Jul 11
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 13
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1